@lydiathurstan.ifbbpro
6 posts audited · 29 claims analysed
Science evidence grade
Based on 29 claims across 6 audits
13
Supported
45%
12
Overstated
41%
0
Misleading
0%
4
No Evidence
14%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @lydiathurstan.ifbbpro claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
45%
13 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
55%
16 claims
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(6 posts)
“Retatrutide, what is it? And why is everyone ALWAYS talking about it. DISCLAIMER, this is for educational purposes only, not medical advice nor advertisement of a product. Let’s break down how this peptide truely works and educate you the RIGHT way. #peptides #nutritionist #weightloss #reta”
The creator's claims about retatrutide's triple-agonist mechanism and the individual roles of GLP-1, GIP, and glucagon are grounded in established endocrinology and supported by completed human clinical trials. The GLP-1 satiety/gastric effect, GIP's glucose-dependent insulin stimulation, and glucagon's energy-mobilization functions are all documented. One claim (Claim 5: GIP preventing 'crashes') is overstated—the mechanism is real but the certainty of outcome is beyond what current trials demonstrate. The compound name 'Redditorutide' appears to be informal nomenclature for retatrutide, creating a minor evidence retrieval gap, but the underlying mechanisms described are scientifically sound.
“NAD+ 💉🩸 Let’s discuss what it does and is it worth taking? #peptides #onlinecoach #health”
The claims about NAD predominantly align with established biochemical understanding, though some specific mechanistic assertions require additional clinical research. The underlying scientific concepts are fundamentally sound, with nuanced evidence supporting NAD's critical cellular roles.
“BPC + TB500 the injury repair stack to solve IT ALL! Let’s discuss what it really does and how they work. #bodybuilding #injury #nutritionist #peptides #bpc”
While BPC-157 shows promising preclinical results in tissue repair and healing mechanisms, the current scientific evidence lacks definitive human clinical validation. More research, particularly human trials, is needed to substantiate the broad claims of tissue repair and healing.
“GHK-CU the new MIRACLE beauty drug ! #peptides #ghk #bodybuilding #weightloss”
While GHK-Cu shows promising preclinical results in tissue regeneration and wound healing, the claims of it being a 'miracle' compound for beauty, bodybuilding, and weight loss are not supported by current scientific evidence. More rigorous human clinical trials are needed to substantiate these broad claims.
“GHK-CU the new MIRACLE beauty drug ! #peptides #ghk #bodybuilding #weightloss”
GHK's copper-binding capacity and in-vitro effects on collagen-related pathways are well-documented in peer-reviewed literature, supporting the mechanistic foundation of claims 1–2. However, claims 3–6 lack direct scientific support: inflammation reduction, gene activation, NF-κB suppression, and skin-tightening cosmetic outcomes have no published preclinical or human evidence. Claim 6 specifically overstates preclinical findings as established cosmetic benefits without human clinical validation. The creator's claims move from evidence-supported mechanistic territory (copper binding, fibroblast collagen synthesis) into unsupported territory (systemic inflammation, specific gene clusters, clinical skin outcomes) without acknowledging the evidence gap.
“BPC + TB500 the injury repair stack to solve IT ALL! Let’s discuss what it really does and how they work. #bodybuilding #injury #nutritionist #peptides #bpc”
The BPC-157 + TB-500 injury repair stack concept is grounded in real preclinical science showing both peptides promote wound healing and tissue repair through complementary mechanisms (angiogenesis, fibroblast activation, ECM remodeling). BPC-157 specifically has active Phase 2 clinical trial support for hamstring strain repair, the strongest evidence available. However, the combination itself lacks human validation, and TB-500 specifically has zero human orthopaedic trials — only animal data. The stack is mechanistically plausible and preclinically supported, but claims of human efficacy would be overstated without acknowledging the evidence remains largely animal-model based.
Audit another post from @lydiathurstan.ifbbpro
Paste their social post link to add a new audit